Raptor Pharmaceuticals acquires cysteamine rights from Seattle Children's Research Institute - MarketLine Financial Deals

Raptor Pharmaceuticals acquires cysteamine rights from Seattle Children's Research Institute

Raptor Pharmaceuticals acquires cysteamine rights from Seattle Children's Research Institute - MarketLine Financial Deals
Raptor Pharmaceuticals acquires cysteamine rights from Seattle Children's Research Institute
Published Oct 10, 2012
2 pages — Published Oct 10, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Raptor Pharmaceuticals Corp., a development-stage biotechnology company, has acquired exclusive world-wide rights to intellectual property related to cysteamine and related compounds in the potential treatment of tissue fibrosis from Seattle Children's Research Institute

  
Source:
Document ID
MA125826_121019
Country
Ticker
RPTP=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Raptor Pharmaceuticals acquires cysteamine rights from Seattle Children's Research Institute" Oct 10, 2012. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Raptor-Pharmaceuticals-acquires-cysteamine-rights-from-Seattle-Children-s-Research-Institute-2052-89311>
  
APA:
MarketLine Financial Deals. (2012). Raptor Pharmaceuticals acquires cysteamine rights from Seattle Children's Research Institute Oct 10, 2012. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Raptor-Pharmaceuticals-acquires-cysteamine-rights-from-Seattle-Children-s-Research-Institute-2052-89311>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.